Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) may improve glycemic control in patients with type 2 diabetes, reducing the risk of disease complications.
Although the importance of evidence-based practice cannot be denied, traditional weight loss programs (TWLPs) have continued to be used despite decades of data discrediting…
Drugs that inhibit dipeptidyl peptidase-4 (DPP-4) may improve glycemic control in patients with type 2 diabetes, reducing the risk of disease complications.
Although the importance of evidence-based practice cannot be denied, traditional weight loss programs (TWLPs) have continued to be used despite decades of…